Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.230
-0.060 (-4.65%)
At close: Apr 28, 2026, 4:00 PM EDT
1.250
+0.020 (1.63%)
Pre-market: Apr 29, 2026, 6:07 AM EDT
Quince Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 20 | 187 | 82 | 45 | 23 | 377 | |
| Market Cap Growth | -54.52% | 126.70% | 82.80% | 95.46% | -93.89% | -53.99% | |
| Enterprise Value | 21 | 178 | 50 | -38 | -71 | 264 | |
| Last Close Price | 1.23 | 33.50 | 18.70 | 10.50 | 6.37 | 126.20 | |
| PB Ratio | - | -5.22 | 2.73 | 0.53 | 0.23 | 3.18 | |
| P/TBV Ratio | - | - | - | 11.89 | 0.24 | 3.18 | |
| Debt / Equity Ratio | -0.52 | -0.52 | 0.49 | 0.16 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.02 | -0.02 | -0.86 | -0.72 | -0.89 | -0.89 | |
| Net Debt / EBITDA Ratio | -0.01 | -0.01 | 0.72 | 2.52 | 1.80 | 1.17 | |
| Net Debt / FCF Ratio | -0.02 | -0.02 | 0.81 | 3.32 | 2.03 | 1.67 | |
| Quick Ratio | 0.49 | 0.49 | 5.73 | 7.95 | 29.71 | 7.59 | |
| Current Ratio | 0.53 | 0.53 | 6.05 | 8.09 | 30.55 | 7.85 | |
| Return on Equity (ROE) | - | - | -98.63% | -33.81% | -47.14% | -61.85% | |
| Return on Assets (ROA) | -30.31% | -30.31% | -16.01% | -11.33% | -26.40% | -34.99% | |
| Return on Capital Employed (ROCE) | -100.30% | -100.30% | -33.70% | -15.60% | -49.70% | -75.90% | |
| Earnings Yield | -418.85% | -45.02% | -69.06% | -69.73% | -224.32% | -23.86% | |
| FCF Yield | -208.36% | -22.40% | -39.09% | -40.99% | -191.80% | -16.74% | |
| Buyback Yield / Dilution | -15.80% | -15.80% | -16.18% | -11.17% | -12.71% | -1.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.